Pfizer raises 2026 guidance after Q3, reports pipeline progress and new CFONov 3Quarterly updateBioNTech SEC4 Therapeutics, Inc.
Dare Bioscience reports Q2 2026 results as first direct product launchesAug 13Quarterly updateDare Bioscience, Inc.